Request Deal Involvement
Mirae Asset Capital Life Science led a $75m Series C funding round in Accent Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Verge Scientific Communications
legal advisors
Jones Day
or
Principals
target
ACCENT THERAPEUTICS
bidder
MIRAE ASSET CAPITAL CO LTD
bidder
MIRAE ASSET VENTURE INVESTMENT
bidder
BRISTOL MYERS SQUIBB COMPANY
bidder
JOHNSON & JOHNSON
bidder
THE COLUMN GROUP
bidder
ATLAS VENTURE LP
bidder
DROIA VENTURES
bidder
ECOR1 CAPITAL
bidder
ABBVIE BIOTECH VENTURES
bidder
TIMEFOLIO ASSET MANAGEMENT
bidder
GV (GOOGLE VENTURES)
bidder
THE MARK FOUNDATION FOR CANCER RESEARCH
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite